Robotic surgery for rectal cancer: An update in 2015

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

During the last decade, robotic surgery for rectal cancer has rapidly gained acceptance among colorectal surgeons worldwide, with well-established safety and feasibility. The lower conversion rate and better surgical specimen quality of robotic compared with laparoscopic surgery potentially improves survival. Earlier recovery of voiding and sexual function after robotic total mesorectal excision is another favorable outcome. Long-term survival data are sparse with no evidence that robotic surgery offers major benefits in oncological outcomes. Although initial reports are promising, more rigorous scientific evaluation in multicenter, randomized clinical trials should be performed to definitely determine the advantages of robotic rectal cancer surgery.

Original languageEnglish
Pages (from-to)427-435
Number of pages9
JournalCancer Research and Treatment
Volume48
Issue number2
DOIs
Publication statusPublished - 2016 Apr 1

Fingerprint

Robotics
Rectal Neoplasms
Laparoscopy
Randomized Controlled Trials
Safety

Keywords

  • Laparoscopy
  • Rectal neoplasms
  • Robotics
  • Total mesorectal excision

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Robotic surgery for rectal cancer : An update in 2015. / Kwak, Jung-Myun; Kim, Seon Hahn.

In: Cancer Research and Treatment, Vol. 48, No. 2, 01.04.2016, p. 427-435.

Research output: Contribution to journalArticle

@article{a6536392896e48d690e54467c2a8b960,
title = "Robotic surgery for rectal cancer: An update in 2015",
abstract = "During the last decade, robotic surgery for rectal cancer has rapidly gained acceptance among colorectal surgeons worldwide, with well-established safety and feasibility. The lower conversion rate and better surgical specimen quality of robotic compared with laparoscopic surgery potentially improves survival. Earlier recovery of voiding and sexual function after robotic total mesorectal excision is another favorable outcome. Long-term survival data are sparse with no evidence that robotic surgery offers major benefits in oncological outcomes. Although initial reports are promising, more rigorous scientific evaluation in multicenter, randomized clinical trials should be performed to definitely determine the advantages of robotic rectal cancer surgery.",
keywords = "Laparoscopy, Rectal neoplasms, Robotics, Total mesorectal excision",
author = "Jung-Myun Kwak and Kim, {Seon Hahn}",
year = "2016",
month = "4",
day = "1",
doi = "10.4143/crt.2015.478",
language = "English",
volume = "48",
pages = "427--435",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Society for Thoracic and Cardiovascular Surgery",
number = "2",

}

TY - JOUR

T1 - Robotic surgery for rectal cancer

T2 - An update in 2015

AU - Kwak, Jung-Myun

AU - Kim, Seon Hahn

PY - 2016/4/1

Y1 - 2016/4/1

N2 - During the last decade, robotic surgery for rectal cancer has rapidly gained acceptance among colorectal surgeons worldwide, with well-established safety and feasibility. The lower conversion rate and better surgical specimen quality of robotic compared with laparoscopic surgery potentially improves survival. Earlier recovery of voiding and sexual function after robotic total mesorectal excision is another favorable outcome. Long-term survival data are sparse with no evidence that robotic surgery offers major benefits in oncological outcomes. Although initial reports are promising, more rigorous scientific evaluation in multicenter, randomized clinical trials should be performed to definitely determine the advantages of robotic rectal cancer surgery.

AB - During the last decade, robotic surgery for rectal cancer has rapidly gained acceptance among colorectal surgeons worldwide, with well-established safety and feasibility. The lower conversion rate and better surgical specimen quality of robotic compared with laparoscopic surgery potentially improves survival. Earlier recovery of voiding and sexual function after robotic total mesorectal excision is another favorable outcome. Long-term survival data are sparse with no evidence that robotic surgery offers major benefits in oncological outcomes. Although initial reports are promising, more rigorous scientific evaluation in multicenter, randomized clinical trials should be performed to definitely determine the advantages of robotic rectal cancer surgery.

KW - Laparoscopy

KW - Rectal neoplasms

KW - Robotics

KW - Total mesorectal excision

UR - http://www.scopus.com/inward/record.url?scp=84963877540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963877540&partnerID=8YFLogxK

U2 - 10.4143/crt.2015.478

DO - 10.4143/crt.2015.478

M3 - Article

C2 - 26875201

AN - SCOPUS:84963877540

VL - 48

SP - 427

EP - 435

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 2

ER -